By Business/Source
Currency:USD
2025/FY
Stock NameRevenueRatio
RECELL66.46M92.81%
Other wound care products4.25M5.93%
Lease revenue731K1.02%
Biomedical Advanced Research and Development Authority (BARDA) revenue for right of first access139K0.19%
Deferred commercial revenue recognized33K0.05%
By Country/Region
Currency:USD
2025/FY
Stock NameRevenueRatio
United States68.79M96.06%
Japan2.09M2.92%
United Kingdom486K0.68%
Australia200K0.28%
European Union49K0.07%